Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NASH - Nonalcoholic Steatohepatitis; NAFLD - Nonalcoholic Fatty Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04342793
What this trial is testing

Evaluate the Efficacy and Safety of ALS-L1023 in Subjects With NASH

Who this might be right for
Nonalcoholic Steatohepatitis
AngioLab, Inc. 60
Testing effectiveness (Phase 2)Study completedNCT01205087
What this trial is testing

Safety and Efficacy of Oral Administration of Anti-CD3 Monoclonal Antibody (mAb)in Patients With the Metabolic Syndrome

Who this might be right for
Nonalcoholic Steatohepatitis
Hadassah Medical Organization 36
Testing effectiveness (Phase 2)Study completedNCT02510599
What this trial is testing

Safety and Efficacy of Solithromycin in the Treatment of Nonalcoholic Steatohepatitis Without Cirrhosis

Who this might be right for
Nonalcoholic Steatohepatitis
Melinta Therapeutics, Inc. 10
Not applicableStudy completedNCT04872777
What this trial is testing

Mobile Health Delivered Lifestyle Intervention Program in Patients With NASH

Who this might be right for
Non-alcoholic Steatohepatitis
Milton S. Hershey Medical Center 40
Testing effectiveness (Phase 2)Study completedNCT04006145
What this trial is testing

Elobixibat in Adults With NAFLD or NASH

Who this might be right for
NAFLDNASH
Albireo 47
Not applicableStudy completedNCT04785937
What this trial is testing

Accuracy of Imaging Techniques in Diagnosing Steatohepatitis and Fibrosis in NAFLD Patients

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseSteatohepatitis, NonalcoholicLiver Fibroses
Azienda USL Reggio Emilia - IRCCS 28
Not applicableStudy completedNCT03260543
What this trial is testing

Efficacy and Safety of Fermented Ginseng Powder on Liver Function

Who this might be right for
Fatty Liver, Nonalcoholic
Chonbuk National University Hospital 90
Testing effectiveness (Phase 2)UnknownNCT06564584
What this trial is testing

Phase 2a Study of Safety, Tolerability, and Efficacy of TLC-2716 in Subjects With Hypertriglyceridemia and NAFLD

Who this might be right for
HypertriglyceridemiaNonalcoholic Fatty Liver Disease
OrsoBio, Inc 30
Testing effectiveness (Phase 2)Ended earlyNCT03617263
What this trial is testing

Saroglitazar Magnesium 4 mg in the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in Women With PCOS (EVIDENCES VII)

Who this might be right for
Non-alcoholic Fatty Liver Disease in Women With PCOS
Zydus Therapeutics Inc. 60
Not applicableStudy completedNCT03858920
What this trial is testing

The Liver in the World Trade Center Health Program General Responder Cohort and Controls

Who this might be right for
Steatosis of LiverNASH - Nonalcoholic Steatohepatitis
Icahn School of Medicine at Mount Sinai 340
Not applicableStudy completedNCT05694923
What this trial is testing

Effect of Sodium Glucose Cotransporter Inhibitors Fatty Liver Disease Patients Fatigue Assessment

Who this might be right for
Fatty Liver Disease
Assiut University 55
Early research (Phase 1)Study completedNCT05560607
What this trial is testing

Knockdown of HSD17B13 mRNA, Pharmacokinetics, Safety, and Tolerability, of AZD7503 in Non-Alcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver DiseaseFatty Liver, NonalcoholicNAFLD+3 more
AstraZeneca 19
Testing effectiveness (Phase 2)Study completedNCT04874233
What this trial is testing

Phase 2a Study of HU6 in Subjects With Elevated Liver Fat and High BMI Volunteers

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Rivus Pharmaceuticals, Inc. 80
Not applicableUnknownNCT04059029
What this trial is testing

Nonalcoholic Fatty Liver Disease in Morbidly Obese Patients

Who this might be right for
Nonalcoholic Fatty Liver Disease (NAFLD)
Taipei Medical University Hospital 200
Not applicableUnknownNCT04355910
What this trial is testing

Intermittent Fasting in Nonalcoholic Fatty Liver Disease

Who this might be right for
Intermittent FastingNon-Alcoholic Fatty Liver DiseaseInsulin Resistance+2 more
Shaoguan University 120
Not applicableStudy completedNCT02132780
What this trial is testing

Autonomic Dysfunction in Non-Alcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver DiseaseNAFLDFatty Liver, Nonalcoholic+1 more
Virginia Commonwealth University 25
Early research (Phase 1)Study completedNCT05012423
What this trial is testing

FTIH Study of ECC0509 in Healthy Volunteers

Who this might be right for
Nonalcoholic SteatohepatitisOsteoarthritis
Eccogene 89
Testing effectiveness (Phase 2)Ended earlyNCT03059446
What this trial is testing

Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis

Who this might be right for
Nonalcoholic SteatohepatitisLiver CirrhosisNon-alcoholic Fatty Liver Disease
Tobira Therapeutics, Inc. 167
Testing effectiveness (Phase 2)Ended earlyNCT01672866
What this trial is testing

Safety and Efficacy of Simtuzumab (SIM, GS-6624) in Adults With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)

Who this might be right for
Liver Fibrosis Due to NASH
Gilead Sciences 222
Not applicableStudy completedNCT03678727
What this trial is testing

Effects of Exercise on VLDL-TG Metabolism

Who this might be right for
NAFLD - Nonalcoholic Fatty Liver DiseaseNASH - Nonalcoholic Steatohepatitis
University of Aarhus 19
Next Page